PharmaTher Holdings Ltd. has launched Personaliz3D Peptides™, a new division focused on personalized peptide therapies using 3D printing and artificial intelligence. This initiative aims to overcome limitations in traditional peptide compounding by offering customized doses, combination formulations, and alternative delivery methods such as gummies and patches. The division plans to integrate telemedicine, physician oversight, and qualified pharmacies into a seamless ecosystem to improve patient access and treatment precision. This launch follows positive FDA advisory committee recommendations that could pave the way for regulated compounded peptides in the U.S., signaling potential growth and innovation in personalized medicine.
The fourth Digital Assets & Tokenization Summit held in Singapore brought together global financial leaders, institutional investors, and tech innovators to discuss how AI, tokenization, and digital assets are transforming capital markets. Key discus...
A London-based novelist, using the pen name A. Nobody, has independently published a thriller titled "A Nobody: London Doesn't Believe in Superheroes." The story follows a masked hero who stops violent crimes in London anonymously, reflecting the aut...
Coastal Community Bank has committed $5 million to the Solomon Hess SBA Loan Fund to support small businesses in Snohomish and King Counties. This investment helps expand access to capital for businesses that may not qualify for traditional loans, fo...
Bitcoin fell 2.19% to $81,605 and Ether dropped 3.93% to $2,412 following hotter-than-expected US inflation data for September. The consumer price index rose 3.7% year-over-year, surpassing forecasts and August's rate, causing $455 million in crypto ...
Three new wallets have staked a combined total of 1.255 million Hyperliquid (HYPE) tokens, valued at approximately $100.43 million. The largest wallet staked 460,180 HYPE ($36.84M), the second 449,900 HYPE ($35.98M), and the third 345,250 HYPE ($27.6...
